Filing Details
- Accession Number:
- 0000899243-21-016134
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-16 19:23:38
- Reporting Period:
- 2021-04-14
- Accepted Time:
- 2021-04-16 19:23:38
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1668397 | Medpace Holdings Inc. | MEDP | Services-Commercial Physical & Biological Research (8731) | 320434904 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1677297 | P Stephen Ewald | C/O Medpace Holdings, Inc. 5375 Medpace Way Cincinnati OH 45227 | General Counsel & Corp. Secy. | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-04-14 | 1,200 | $28.32 | 15,054 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-04-14 | 1,200 | $180.67 | 13,854 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2021-04-15 | 3,800 | $28.32 | 17,654 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-04-15 | 3,800 | $185.18 | 13,854 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-04-14 | 1,200 | $0.00 | 1,200 | $28.32 |
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2021-04-15 | 3,800 | $0.00 | 3,800 | $28.32 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 3,800 | 2021-03-15 | 2024-03-15 | No | 4 | M | Direct |
| 0 | 2021-03-15 | 2024-03-15 | No | 4 | M | Direct |
Footnotes
- The sales reported on this Form 4 were effected pursuant to a limit order placed by the Reporting Person during an open window period.
- The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $180.11 to $181.28. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
- The reported price is a weighted average price. These shares were sold in multiple transactions ranging from $181.13 to $187.07. The Reporting Person undertakes to provide full pricing information to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission upon request.
- Each option vested on March 15, 2021.
Billionaire Hedge Funds
